Heart palpitations generally increase while pregnant because the heart works overtime as the fetus grows. Learn how to keep ...

A 68-year-old woman in Hyderabad survived multiple cardiac arrests with advanced treatment at Care Hospitals. Read about her ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, is proud to announce key milestones achieved throughout 2024, underscoring a year defined by accelerated growth, ...

Clinical Electrophysiology journal showed that when acute procedural success is attained in a subset of patients with ...

Droperidol was a first-line, highly effective agent for the treatment of PONV for over 30 years. It has the most postmarketing surveillance data of any of the currently used antiemetic agents.

Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by high risks of sustained ventricular tachycardia (sVT) and sudden cardiac death. Identifying patients ...

A cardiac surgeon using stem cells to test the effects of radiation as a treatment for ventricular tachycardia is the latest winner of a prestigious award at the McGill University Health Centre (MUHC) ...

A 62-year-old patient, with no prior medical history, was presented with ventricular tachycardia and was ultimately diagnosed with MINOCA after extensive investigation. The underlying cause of her ...

Thus, the interlacing of viable and nonviable myocardium is capable of satisfying the three conditions required for initiation and maintenance of a reentrant rhythm: (1) at least two functionally ...

It has been shown to terminate ventricular tachycardia, and it has been given to suppress multiple ventricular extrasystoles. 1,2 The drug has been administered as an intravenous bolus or as a ...

Despite landiolol's efficacy in managing supraventricular tachycardia, it is contraindicated in cases of pulmonary hypertension due to the risk of cardiorespiratory decompensation. The US Food and ...